118 related articles for article (PubMed ID: 16087404)
1. Alzheimer's disease: an intracellular movement disorder?
Zhu X; Moreira PI; Smith MA; Perry G
Trends Mol Med; 2005 Sep; 11(9):391-3. PubMed ID: 16087404
[TBL] [Abstract][Full Text] [Related]
2. Trafficking of Alzheimer's disease-related membrane proteins and its participation in disease pathogenesis.
Suzuki T; Araki Y; Yamamoto T; Nakaya T
J Biochem; 2006 Jun; 139(6):949-55. PubMed ID: 16788045
[TBL] [Abstract][Full Text] [Related]
3. Do axonal defects in tau and amyloid precursor protein transgenic animals model axonopathy in Alzheimer's disease?
Götz J; Ittner LM; Kins S
J Neurochem; 2006 Aug; 98(4):993-1006. PubMed ID: 16787410
[TBL] [Abstract][Full Text] [Related]
4. Linking molecular motors to Alzheimer's disease.
Stokin GB; Goldstein LS
J Physiol Paris; 2006; 99(2-3):193-200. PubMed ID: 16459060
[TBL] [Abstract][Full Text] [Related]
5. Age-dependent axonal degeneration in an Alzheimer mouse model.
Wirths O; Weis J; Kayed R; Saido TC; Bayer TA
Neurobiol Aging; 2007 Nov; 28(11):1689-99. PubMed ID: 16963164
[TBL] [Abstract][Full Text] [Related]
6. Increased Abeta production leads to intracellular accumulation of Abeta in flotillin-1-positive endosomes.
Rajendran L; Knobloch M; Geiger KD; Dienel S; Nitsch R; Simons K; Konietzko U
Neurodegener Dis; 2007; 4(2-3):164-70. PubMed ID: 17596711
[TBL] [Abstract][Full Text] [Related]
7. The role of intracellular amyloid beta in Alzheimer's disease.
Li M; Chen L; Lee DH; Yu LC; Zhang Y
Prog Neurobiol; 2007 Oct; 83(3):131-9. PubMed ID: 17889422
[TBL] [Abstract][Full Text] [Related]
8. The early events of Alzheimer's disease pathology: from mitochondrial dysfunction to BDNF axonal transport deficits.
Ye X; Tai W; Zhang D
Neurobiol Aging; 2012 Jun; 33(6):1122.e1-10. PubMed ID: 22212405
[TBL] [Abstract][Full Text] [Related]
9. Axonopathy in an APP/PS1 transgenic mouse model of Alzheimer's disease.
Wirths O; Weis J; Szczygielski J; Multhaup G; Bayer TA
Acta Neuropathol; 2006 Apr; 111(4):312-9. PubMed ID: 16520967
[TBL] [Abstract][Full Text] [Related]
10. Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration.
Salehi A; Delcroix JD; Belichenko PV; Zhan K; Wu C; Valletta JS; Takimoto-Kimura R; Kleschevnikov AM; Sambamurti K; Chung PP; Xia W; Villar A; Campbell WA; Kulnane LS; Nixon RA; Lamb BT; Epstein CJ; Stokin GB; Goldstein LS; Mobley WC
Neuron; 2006 Jul; 51(1):29-42. PubMed ID: 16815330
[TBL] [Abstract][Full Text] [Related]
11. BACE inhibitor reduces APP-beta-C-terminal fragment accumulation in axonal swellings of okadaic acid-induced neurodegeneration.
Yoon SY; Choi JE; Yoon JH; Huh JW; Kim DH
Neurobiol Dis; 2006 May; 22(2):435-44. PubMed ID: 16480887
[TBL] [Abstract][Full Text] [Related]
12. [A new hypothesis for early pathogenesis in Alzheimer's disease: impaired axonal transport mechanism].
Zhu YB; Lu PH; Sheng ZH
Sheng Li Ke Xue Jin Zhan; 2008 Jan; 39(1):5-9. PubMed ID: 18357680
[TBL] [Abstract][Full Text] [Related]
13. Amyloid precursor protein and mitochondrial dysfunction in Alzheimer's disease.
Anandatheerthavarada HK; Devi L
Neuroscientist; 2007 Dec; 13(6):626-38. PubMed ID: 17911214
[TBL] [Abstract][Full Text] [Related]
14. Cystatin C inhibits amyloid-beta deposition in Alzheimer's disease mouse models.
Mi W; Pawlik M; Sastre M; Jung SS; Radvinsky DS; Klein AM; Sommer J; Schmidt SD; Nixon RA; Mathews PM; Levy E
Nat Genet; 2007 Dec; 39(12):1440-2. PubMed ID: 18026100
[TBL] [Abstract][Full Text] [Related]
15. A decade of modeling Alzheimer's disease in transgenic mice.
McGowan E; Eriksen J; Hutton M
Trends Genet; 2006 May; 22(5):281-9. PubMed ID: 16567017
[TBL] [Abstract][Full Text] [Related]
16. Axonal accumulation of synaptic markers in APP transgenic Drosophila depends on the NPTY motif and is paralleled by defects in synaptic plasticity.
Rusu P; Jansen A; Soba P; Kirsch J; Löwer A; Merdes G; Kuan YH; Jung A; Beyreuther K; Kjaerulff O; Kins S
Eur J Neurosci; 2007 Feb; 25(4):1079-86. PubMed ID: 17331204
[TBL] [Abstract][Full Text] [Related]
17. Amyloid precursor protein-mediated free radicals and oxidative damage: implications for the development and progression of Alzheimer's disease.
Reddy PH
J Neurochem; 2006 Jan; 96(1):1-13. PubMed ID: 16305625
[TBL] [Abstract][Full Text] [Related]
18. Prolonged stress will induce Alzheimer's disease in elderly people by increased release of homocysteic acid.
Hasegawa T
Med Hypotheses; 2007; 69(5):1135-9. PubMed ID: 17499446
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of A beta mediated neurodegeneration in Alzheimer's disease.
Crouch PJ; Harding SM; White AR; Camakaris J; Bush AI; Masters CL
Int J Biochem Cell Biol; 2008; 40(2):181-98. PubMed ID: 17804276
[TBL] [Abstract][Full Text] [Related]
20. Noradrenaline deficiency in brain increases beta-amyloid plaque burden in an animal model of Alzheimer's disease.
Kalinin S; Gavrilyuk V; Polak PE; Vasser R; Zhao J; Heneka MT; Feinstein DL
Neurobiol Aging; 2007 Aug; 28(8):1206-14. PubMed ID: 16837104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
